Related Experiment Video

Updated: Jun 4, 2026

Evaluation of Changes in Hydration and Body Cell Mass with Bioelectrical Impedance Analysis after Exercise Program for Rheumatoid Arthritis Patients
07:44

Evaluation of Changes in Hydration and Body Cell Mass with Bioelectrical Impedance Analysis after Exercise Program for Rheumatoid Arthritis Patients

Published on: July 14, 2023

[Excess mortality from cardiovascular disease in patients with rheumatoid arthritis]

Jesper Lindhardsen1, Gunnar Hilmar Gislason, Ole Ahlehoff

  • 1Kardiologisk Afdeling P, Gentofte Hospital, Hellerup, Denmark. jesper@lindhardsen.net

Ugeskrift for Laeger
|February 1, 2011
PubMed

Insights

Rheumatoid arthritis patients face high cardiovascular risks, similar to type 2 diabetes patients. New guidelines offer evidence-based strategies for managing this elevated cardiovascular risk in rheumatoid arthritis.

Area of Science:

  • Rheumatology
  • Cardiology
  • Immunology

Context:

  • Rheumatoid arthritis (RA) is associated with significantly increased cardiovascular morbidity and mortality.
  • The cardiovascular risk in RA patients is comparable to that observed in patients with type 2 diabetes mellitus.
  • Existing research highlights a critical need for focused cardiovascular risk management in RA.

Purpose:

  • To summarize the European League Against Rheumatism (EULAR) evidence-based guidelines for cardiovascular risk management in rheumatoid arthritis.
  • To present recent data and insights concerning cardiovascular risk in RA patients.
  • To provide clinicians with actionable information for managing cardiovascular health in individuals with RA.

Summary:

  • Cardiovascular morbidity and mortality are substantially elevated in patients with rheumatoid arthritis.
  • These risks are comparable to those seen in patients diagnosed with type 2 diabetes mellitus.
  • The European League Against Rheumatism has issued guidelines for cardiovascular risk management tailored to RA patients.

Impact:

  • Improved understanding of the significant cardiovascular burden in rheumatoid arthritis.
  • Facilitation of the implementation of EULAR guidelines for better patient outcomes.
  • Enhanced clinical practice regarding cardiovascular risk assessment and mitigation in RA patients.

Related Concept Videos

Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...